Bioventus
BVS
BVS
151 hedge funds and large institutions have $478M invested in Bioventus in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 46 increasing their positions, 51 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 51
11% less capital invested
Capital invested by funds: $537M → $478M (-$59.3M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
151
Holding in Top 10
3
Calls
$2.71M
Puts
$775K
Top Buyers
| 1 | +$8.42M | |
| 2 | +$4.08M | |
| 3 | +$3.26M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.96M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$2.59M |
Top Sellers
| 1 | -$4.21M | |
| 2 | -$3.83M | |
| 3 | -$3.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.23M |